Long-term impacts of antibiotic exposure on the human intestinal microbiota, Microbiology, vol.156, pp.3216-3239, 2010. ,
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation, Proc Natl Acad Sci U S A, vol.108, issue.1, pp.4554-61, 2011. ,
Gut microbiota disturbance during antibiotic therapy: a multiomic approach, Gut, vol.62, pp.1591-601, 2013. ,
Role of the microbiota in immunity and inflammation, Cell, vol.157, pp.121-162, 2014. ,
Antibiotics in early life and obesity, Nat Rev Endocrinol, vol.11, pp.182-90, 2015. ,
Resistance to fluoroquinolones in 2010: what are the consequences for prescriptions in intensive care units?, Réanimation, vol.19, pp.347-53, 2010. ,
Disruption of the gut microbiome: Clostridium difficile infection and the threat of antibiotic resistance, Genes (Basel), vol.6, pp.1347-60, 2015. ,
Clostridium difficile infection, N Engl J Med, vol.372, pp.1539-1587, 2015. ,
Metaanalysis of antibiotics and the risk of community-associated Clostridium difficile infection, Antimicrob Agents Chemother, vol.57, pp.2326-2358, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02401778
Communityassociated Clostridium difficile infection and antibiotics: a meta-analysis, J Antimicrob Chemother, vol.68, pp.1951-61, 2013. ,
Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis, J Antimicrob Chemother, vol.69, pp.881-91, 2014. ,
The human intestinal microbiome in health and disease, N Engl J Med, vol.375, pp.2369-79, 2016. ,
MetaHIT Consortium. Human gut microbes impact host serum metabolome and insulin sensitivity, Nature, vol.535, pp.376-81, 2016. ,
Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences, Cell, vol.158, pp.705-726, 2014. ,
MetaHIT Consortium. Richness of human gut microbiome correlates with metabolic markers, Nature, vol.500, pp.541-547, 2013. ,
Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization, J Infect Dis, vol.160, pp.274-80, 1989. ,
Oral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice, J Infect Dis, vol.188, pp.1605-1614, 2003. ,
Orally administered beta-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile, J Antimicrob Chemother, vol.62, pp.1105-1113, 2008. ,
IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microflora, Curr Opin Investig Drugs Lond Engl, vol.10, pp.838-882, 2000. ,
SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model, J Appl Microbiol, 2017. ,
Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads, Eur J Pharm Sci, vol.41, pp.281-289, 2010. ,
Targeted adsorption of molecules in the colon with the novel adsorbent-based medicinal product, DAV132: a proof of concept study in healthy subjects, J Clin Pharmacol, vol.55, pp.10-16, 2015. ,
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora, Scand J Infect Dis, vol.32, pp.81-86, 2000. ,
Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis ,
, Appl Environ Microbiol, vol.63, pp.2802-2815, 1997.
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut, Appl Environ Microbiol, vol.65, pp.4799-807, 1999. ,
MetaHIT Consortium; MetaHIT Consortium. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes, Nat Biotechnol, vol.32, pp.822-830, 2014. ,
ANR MicroObes consortium. Dietary intervention impact on gut microbial gene richness, Nature, vol.500, pp.585-593, 2013. ,
Aligning short sequencing reads with Bowtie, Curr Protoc Bioinforma, 2010. ,
, , 2010.
Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males, Br J Clin Pharmacol, vol.59, pp.536-577, 2005. ,
Microbiological effects of sublethal levels of antibiotics, Nat Rev Microbiol, vol.12, pp.465-78, 2014. ,
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria, J Infect Dis, vol.200, pp.390-398, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00409776
Protection of hamsters from mortality by reducing fecal moxifloxacin concentration with DAV131A in a model of moxifloxacin-induced Clostridium difficile colitis, Antimicrob Agents Chemother, vol.61, pp.543-560, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01590774